Transcutaneous vagus nerve stimulation for depression may influence more than mood symptoms. New research suggests that a single session could help people with severe depression allocate effort more efficiently when making decisions about rewards.
The finding introduces a potentially important direction for neuromodulation research. Instead of measuring symptom reduction alone, investigators examined whether stimulation changed a specific motivational process that can become disrupted in major depressive disorder.
Why Motivation Remains A Difficult Treatment Target
Depression is often associated with anhedonia, reduced motivation, and difficulty deciding whether a goal is worth the effort required. These problems can affect work, relationships, treatment participation, and everyday activities.
Standard depression assessments capture parts of this experience, but they do not always explain how patients evaluate costs and benefits in real time. Previous research has largely focused on whether people with depression are less willing to exert effort for a larger reward.
The new study examined a more nuanced possibility. Some patients may expend additional effort even when doing so provides no added benefit. This inefficient allocation of limited physical or cognitive resources may represent another dimension of motivational dysfunction.
Testing Transcutaneous Vagus Nerve Stimulation For Depression
Researchers studied 98 participants, including 53 people with major depressive disorder and 45 non-depressed controls. The randomized, single-blind crossover trial compared active transcutaneous auricular vagus nerve stimulation, known as tVNS, with sham stimulation.
Each participant attended two testing sessions. Active stimulation was delivered through the cymba conchae of the right ear, while sham stimulation was applied to the earlobe. The stimulation condition was the only major difference between sessions, allowing participants to serve as their own comparison.
During stimulation, participants completed a grip-strength task involving monetary rewards. On each trial, they chose between an easier option requiring 50 percent of their maximum grip strength and a harder option requiring 90 percent.
Sometimes the harder choice produced a larger reward. On other trials, both choices offered the same amount.
A Model Of Reward-Effort Efficiency
This design allowed researchers to distinguish between necessary and unnecessary effort.
Choosing the harder task for a larger reward represented necessary effort. Choosing it when the easier task offered the same reward represented unnecessary effort. Reward-effort efficiency reflected how consistently participants maximized rewards without spending more effort than required.
This distinction matters because motivation is not simply the willingness to work harder. Adaptive motivation also requires recognizing when additional effort is unlikely to improve the outcome.
Benefits Appeared Only With Severe Symptoms
The primary analysis found no significant difference in the effect of stimulation between the overall depression and control groups.
A secondary analysis, however, showed that the response varied with depressive symptom severity. Among 19 participants with severe symptoms, estimated reward-effort efficiency increased from 89.4 percent during sham stimulation to 94.6 percent during active tVNS.
No comparable improvement appeared among participants with mild-to-moderate or minimal symptoms. The change in the severe group was primarily driven by fewer unnecessary high-effort choices, rather than a greater willingness to work for larger rewards.
In practical terms, stimulation appeared to make effort allocation more selective. Participants did not simply become more active or motivated across every decision.
How Vagus Stimulation Could Influence Motivation
The vagus nerve connects internal organs with brainstem systems involved in arousal, learning, emotion, and reward. Stimulating its auricular branches may influence noradrenergic, dopaminergic, and serotonergic pathways associated with cost-benefit decision-making.
Dopamine helps the brain integrate expected rewards with anticipated effort. Noradrenaline may support the dynamic adjustment of effort as task demands change. Modulation of these systems offers one possible explanation for the behavioral findings, although the study did not directly establish a biological mechanism.
Another possibility is that tVNS improved broader executive abilities, such as cognitive flexibility, rather than motivation specifically.
A Different View Of Depression-Related Effort
Unlike earlier studies measuring button-press speed or effort maintenance, this trial evaluated decisions made before effort was exerted. It therefore captured how participants used reward and effort information, not simply how vigorously they performed.
The crossover design and successful participant blinding strengthened the comparison. Still, the most clinically interesting results came from secondary analyses, and the severe-symptom subgroup was small.
What Comes Next For Clinical Research
The findings do not establish tVNS as a treatment for motivational impairment. They show an acute laboratory effect following one session, not a sustained improvement in daily functioning or depression severity.
Larger trials will need to determine whether the result can be replicated, persists across repeated sessions, and translates into meaningful behavioral change. Neuroimaging and pharmacological studies could also clarify whether dopamine, noradrenaline, executive function, or multiple interacting systems drive the effect.
For now, the study supports a more precise question for the field: whether neuromodulation can help patients use effort more effectively, rather than merely increasing effort overall.
Citations
Forbes, P. A. G., et al. “Transcutaneous Vagus Nerve Stimulation Enhances Reward-Effort Efficiency in Severe Major Depressive Disorder.” Journal of Affective Disorders, 2026. https://doi.org/10.1016/j.jad.2026.122193
Li, S., et al. “Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder.” Neuromodulation, 2022. https://doi.org/10.1016/j.neurom.2021.10.021
Explore more at https://www.interventionalpsychiatry.org/
